153 related articles for article (PubMed ID: 36544917)
41. Clinicopathological presentation of tongue cancers and early cancer treatment.
Najeeb T
J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
[TBL] [Abstract][Full Text] [Related]
42. Outcomes for patients with second primary malignancy after primary surgical treatment for early-stage squamous cell carcinoma of the oral cavity.
Suton P; Prpic M; Tarle M; Mamic M; Nikles I; Luksic I
Head Neck; 2018 Nov; 40(11):2347-2352. PubMed ID: 30302872
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
Naruse T; Yanamoto S; Okuyama K; Ohmori K; Tsuchihashi H; Furukawa K; Yamada SI; Umeda M
Pathol Oncol Res; 2020 Apr; 26(2):735-742. PubMed ID: 30767115
[TBL] [Abstract][Full Text] [Related]
44. Factors related to regional recurrence in early stage squamous cell carcinoma of the oral tongue.
An SY; Jung EJ; Lee M; Kwon TK; Sung MW; Jeon YK; Kim KH
Clin Exp Otorhinolaryngol; 2008 Sep; 1(3):166-70. PubMed ID: 19434251
[TBL] [Abstract][Full Text] [Related]
45. Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations.
Thangaraj SV; Shyamsundar V; Krishnamurthy A; Ramani P; Ganesan K; Muthuswami M; Ramshankar V
PLoS One; 2016; 11(6):e0156582. PubMed ID: 27280700
[TBL] [Abstract][Full Text] [Related]
46. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
47. Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.
Almangush A; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Coletta RD; Salo T; Leivo I
Virchows Arch; 2018 Oct; 473(4):481-487. PubMed ID: 30039390
[TBL] [Abstract][Full Text] [Related]
48. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
[TBL] [Abstract][Full Text] [Related]
49. Impact of Clinical and Histo-Pathological Prognostic Factors on T1-2N0-1 Oral Tongue Carcinoma.
Sittitrai P; Srivanitchapoom C; Mahanupab P; Pattarasakulchai T; Tananuvat R; Unejanum W
Indian J Otolaryngol Head Neck Surg; 2013 Jan; 65(1):66-70. PubMed ID: 24381924
[TBL] [Abstract][Full Text] [Related]
50. A simple novel prognostic model for early stage oral tongue cancer.
Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
[TBL] [Abstract][Full Text] [Related]
51. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
52. Stromal categorization in early oral tongue cancer.
Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
[TBL] [Abstract][Full Text] [Related]
53. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
54. Outcome of per oral wide excision of T1-2 N0 localized squamous cell cancer of the buccal mucosa--analysis of 156 cases.
Hakeem AH; Pradhan SA; Tubachi J; Kannan R
Laryngoscope; 2013 Jan; 123(1):177-80. PubMed ID: 22952001
[TBL] [Abstract][Full Text] [Related]
55. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
[TBL] [Abstract][Full Text] [Related]
56. Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years.
Faisal M; Dhanani R; Ullah S; Bakar MA; Irfan N; Malik KI; Loya A; Boban EM; Hussain R; Jamshed A
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3045-3053. PubMed ID: 33236214
[TBL] [Abstract][Full Text] [Related]
57. Relapse patterns and related prognostic factors in patients with mobile tongue cancer treated with postoperative radiotherapy.
Kamer S; Esassolak M; Demirci S; Akyildiz S; Sengul A; Yavuzer A
J BUON; 2009; 14(1):51-6. PubMed ID: 19373947
[TBL] [Abstract][Full Text] [Related]
58. [Recurrence of cancer of the paranasal sinuses after primary treatment--analysis of conditions and results of salvage treatment].
Zyłka S; Zawadzki M; Postuła S; Bień S
Otolaryngol Pol; 2010 Jun; 64(7):44-9. PubMed ID: 21171311
[TBL] [Abstract][Full Text] [Related]
59. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
